Stansberry Asset Management, LLC Editas Medicine, Inc. Transaction History

Stansberry Asset Management, LLC

  • $721 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$14.08 - $27.63 $395,436 - $775,988
-28,085 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$26.55 - $40.57 $447,473 - $683,766
16,854 Added 150.07%
28,085 $746,000
Q3 2021

Nov 15, 2021
BUY
$39.27 - $72.94 $441,041 - $819,189
11,231 New
11,231 $461,000

Others Institutions Holding EDIT

# of Institutions
248
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $90M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Stansberry Asset Management, LLC Portfolio

Follow Stansberry Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stansberry Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stansberry Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email